Enhancing the Activity of BH3 Mimetic Drugs in Blood Cancers

Grant number: RCH0240794 null | Funding period: 2025 - 2029

Active

Related publications (2)

Scholarly works icon

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia

DM Brander, AW Roberts, TJ Kipps, S Ma, MA Anderson, M Boyer, P Blombery, R Popovic, J Roser, Z Liu, B Chyla, JF Seymour

2025-12-01

Scholarly works icon

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer

IS Tiong, T Nguyen, CC Chua, CE Teh, C Muttiah, S Ftouni, JF Seymour, D Gray, AW Roberts, SJ Dawson, GJ Lindeman, P Blombery

2025-09-09

University of Melbourne Researchers